GENEVA, May 5 -- EISBACH BIO GMBH (Am Klopferspitz 1982152 Martinsried) filed a patent application (PCT/EP2024/080170) for "A PYRIDO-THIENO-PYRIMIDIN DERIVATIVE AS ALC1 INHIBITOR FOR USE IN THE TREATMENT OF HOMOLOGOUS RECOMBINATION DEFICIENCY (HRD) CANCERS" on Oct 25, 2024. With publication no. WO/2025/088087, the details related to the patent application was published on May 01, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MENZER, William (Einsteinstr. 382152 Planegg), LECHNER, Markus (Tizianplatz 7Munich 80638), SCHOMBURG, Adrian (Friedemann-Bach-Str. 9582166 Grafelfing)
Abstract:
Th...